Format

Send to

Choose Destination
Oncotarget. 2017 May 30;8(22):35492-35507. doi: 10.18632/oncotarget.18033.

From rapalogs to anti-aging formula.

Author information

1
Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA.

Abstract

Inhibitors of mTOR, including clinically available rapalogs such as rapamycin (Sirolimus) and Everolimus, are gerosuppressants, which suppress cellular senescence. Rapamycin slows aging and extends life span in a variety of species from worm to mammals. Rapalogs can prevent age-related diseases, including cancer, atherosclerosis, obesity, neurodegeneration and retinopathy and potentially rejuvenate stem cells, immunity and metabolism. Here, I further suggest how rapamycin can be combined with metformin, inhibitors of angiotensin II signaling (Losartan, Lisinopril), statins (simvastatin, atorvastatin), propranolol, aspirin and a PDE5 inhibitor. Rational combinations of these drugs with physical exercise and an anti-aging diet (Koschei formula) can maximize their anti-aging effects and decrease side effects.

KEYWORDS:

diseases; health; lifespan; longevity; rejuvenation

PMID:
28548953
PMCID:
PMC5482593
DOI:
10.18632/oncotarget.18033
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center